U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.802G>A (p.Glu268Lys) AND Monogenic diabetes

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 5, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003403215.1

Allele description [Variation Report for NM_000162.5(GCK):c.802G>A (p.Glu268Lys)]

NM_000162.5(GCK):c.802G>A (p.Glu268Lys)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.802G>A (p.Glu268Lys)
Other names:
NM_000162.5(GCK):c.802G>A; p.Glu268Lys
HGVS:
  • NC_000007.14:g.44147711C>T
  • NG_008847.2:g.55460G>A
  • NM_000162.5:c.802G>AMANE SELECT
  • NM_001354800.1:c.802G>A
  • NM_033507.3:c.805G>A
  • NM_033508.3:c.799G>A
  • NP_000153.1:p.Glu268Lys
  • NP_001341729.1:p.Glu268Lys
  • NP_277042.1:p.Glu269Lys
  • NP_277043.1:p.Glu267Lys
  • LRG_1074t1:c.802G>A
  • LRG_1074t2:c.805G>A
  • LRG_1074:g.55460G>A
  • LRG_1074p1:p.Glu268Lys
  • LRG_1074p2:p.Glu269Lys
  • NC_000007.13:g.44187310C>T
  • NM_000162.3:c.802G>A
  • p.GLU268LYS
Protein change:
E267K
Links:
dbSNP: rs1554335111
NCBI 1000 Genomes Browser:
rs1554335111
Molecular consequence:
  • NM_000162.5:c.802G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.802G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.805G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.799G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004102862ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Monogenic Diabetes ACMG Specifications GCK V1.3.0)		Pathogenic
(Oct 5, 2023) 		germlinecuration

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004102862.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.802G>A variant in the glucokinase gene, GCK, causes an amino acid change of glutamic acid to lysine at codon 268 (p.(Glu268Lys)) of NM_000162.5. This variant segregated with diabetes/hyperglycemia, with four informative meioses in two families (PP1_Strong; internal lab contributors). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in eight unrelated individuals with hyperglycemia (PS4; internal lab contributors). This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and negative antibodies) (PP4_Moderate; internal lab contributors). GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.727, which is greater than the MDEP VCEP threshold of 0.70 (PP3). In summary, c.802G>A meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PP1_Strong, PS4, PP4_Moderate, PP2, PP3, PM2_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024